Date/time

Session typemin

TopicSpeaker

Affiliation

Koya Ariyoshi, JohnEdmunds

Nagasaki U, LSHTM

Aki Moriya

Nagasaki U,.

Sep 24 – Sep 27: Vaccinology: Science and Public Health – Short course (didactic and interactive sessions)Sep 24. 2024 - Tue
25 Welcome and overview of course objectives
8:30 – 8:55

Introduction of faculty and course participantsGroup photo

9:00 – 9:25

Lecture25 History of vaccines

David Heymann

LSHTM

9:30 – 10:20

Lecture50 Basic immunology

Ken Ishii

University of Tokyo

10:30 – 11:20

Lecture50 Vaccine types, Modality and platforms of vaccines

Ken Ishii

University of Tokyo

11:30 – 12:00

Lecture30 Target product profile

Sushant SahastrabuddheInternational Vaccine
Insitute, Seoul

12:00 – 13:00

Lunch

13:00 – 13:50

Lecture50 AI for vaccine development

Sebastian Kapell

NEC OncoImmunity
AS

14:00 – 14:50

Lecture50 Vaccine development and manufacturing

Motoharu Abe

KM Biologics

15:00 – 16:00

Practical

60 Role play H5N1 and WHODavid Heymann

LSHTM

16:10 – 16:30

Lecture20 Evidence to recommendation criteria for NITAGs (WHO guidelines)

Kaja Abbas

Nagasaki U/LSHTM

16:30 – 16:50

Group work

Introduction of group activity (Vaccine development & NITAG decisionmaking)
20 and discussion among individual groups

Hyolim Kang, Sol Kim

Nagasaki U/LSHTM

15 Vaccines against congenital infections - rubella

Michiko Toizumi

Nagasaki University

15 Leishmaniasis vaccine

Shinjiro Hamano

Nagasaki University

15 Chikungunya vaccine clinical trials

Sushant Sahastrabuddhe

IVI, Seoul

15 Q/A and panel discussion

Chair: Ken Ishii

University of Tokyo

17:00 – 18:00

18:00 – 20:00

Speciallecture/researchseminarSocial evening - Mount Inasa (optional)

Date/time

Session typemin

TopicSpeakerAffiliation

Sep 25. 2024 - Wed

8:30 – 8:55

Group
discussion/reflecti
on25 Group discussion by students to reflect on their learning (of past day)

Kaja Abbas

Nagasaki U/LSHTM

9:00 – 9:50

Lecture50 Surveillance and burden estimation

David Heymann

LSHTM

10:00 – 10:50

Lecture50 Vaccine efficacy, effectiveness, correlates of protection

Aki Moriya

Nagasaki University

11:00 – 12:00

Lecture60 Clinical trial designs

John Edmunds

LSHTM

12:00 – 13:00

Lunch

13:00 – 13:50

Lecture50 Vaccine evaluation - pre-licensure and post-licensure stages

Kaja Abbas

LSHTM

14:00 – 14:25

Lecture25 Licensing and regulatory aspects

Mugen Ujiie

NCGM, Tokyo

14:30 – 14:55

Lecture25 Post-licensure pharmacovigilance (vaccine safety)

Ivo Vojtek

GSK Japan

15:00 – 16:00

Practical

60 Vaccine evaluation practical

Kaja Abbas

LSHTM

16:05 – 16:55

Group work

50 Discussion among individual groups

Hyolim Kang, Sol Kim

Nagasaki U/LSHTM

15 Menongoccal vaccination

Caroline Trotter

Cambridge University& Imperial CollegeLondon

15 Ebola vaccine trials

John Edmunds

LSHTM

Power of vaccines: from the eradication of smallpox and polio to the fight15 against antimicrobial resistanceDavid Heymann

LSHTM

15 Q/A and panel discussion

Chair: Kouichi Morita

Nagasaki University

17:00 – 18:00

Speciallecture/researchseminar

Date/timeSession typeminTopicSpeaker

Affiliation

Sep 26. 2024 - Thu

8:30 – 8:55

Group
discussion/reflecti
on

25 Group discussion by students to reflect on their learning (of past day)

Kaja Abbas

LSHTM

9:00 – 9:50

Lecture50 Infectious disease modelling

Laura Skrip

Nagasaki U/LSHTM

10:00 – 10:50

Lecture50 Vaccine impact modelling

Caroline Trotter

Cambridge University& Imperial CollegeLondon

11:00 – 11:50

Lecture50 Vaccine economics

Kaja Abbas

LSHTM

12:00 – 13:00

Lunch

13:00 – 13:50

Lecture50 Economic evaluation of immunization programmes (WHO guidelines)

Mark Jit

New York University

14:00 – 14:25

Lecture25 Full value of vaccine assessment

Mark Jit

New York University

14:30 – 14:55

Lecture25 Vaccine delivery

Yasuhiko KamiyaNagasaki University

15:00 – 16:00

Practical

60 Computer practical: Cost-effectiveness analysis of vaccination (Excel)

Mark Jit

New York University

16:05 – 16:55

Group work

50 Discussion among individual groups

Hyolim Kang, Sol KimNagasaki U/LSHTM

15 Dynamics of defining immunisation policy - HPV in UK

Mark Jit

New York University

17:00 – 18:00

Speciallecture/researchseminar

15 HPV vaccine hesistancy and decision-making in Japan

Hana Tomoi

Nagasaki U/LSHTM

15 HPV vaccination in Japan and Asian countries, and future opportunities

Noriko Fujita

Nagasaki University

15 Q/A and panel discussion

Chair: Hiroyuki Moriuchi

Nagasaki University

Date/time

Session type

minTopicSpeaker

Affiliation

Sep 27. 2024 - Fri

8:30 – 8:55

Group
discussion/reflecti
on25 Group discussion by students to reflect on their learning (of past day)

Kaja Abbas

Nagasaki U/LSHTM

9:00 – 9:25

Lecture25 Vaccines and AMRDavid Heymann

LSHTM

9:30 – 9:55

Lecture25 Pneumococcal vaccines

Bhim Gopal Dhoubhadel

Nagasaki University

10:00 – 10:25

Lecture25 Vaccine confidence and hesitancy

Hana Tomoi

Nagasaki U/LSHTM

10:30 – 10:55

LectureSocial mobilisation and risk communication strategies to promote
25 vaccination behaviours

Laura Skrip

Nagasaki U/LSHTM

11:00 – 11:25

Lecture25 Vaccines and climate change

Hyolim Kang

Nagasaki U/LSHTM

11:30 – 11:55

Lecture25 Pandemic preparedness

Aurélia Vessière

Nagasaki U/LSHTM

12:00 – 12:15

Group
discussion/reflection

15 Group discussion by students to reflect on their learning (of today)

Kaja Abbas

Nagasaki U/LSHTM

12:15 – 14:30

Lunch and preptime

14:30 – 16:30

Grouppresentation

120 Presentations by groups (Vaccine development & NITAG decision-making)Students

16:30 – 17:00

Closing ceremony

30 Course feedback and closing remarks

Koya Ariyoshi

Nagasaki University